| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.50B | 41.96B | 38.66B | 31.96B | 34.16B | 33.14B |
| Gross Profit | 7.77B | 9.05B | 9.06B | 7.60B | 9.03B | 8.39B |
| EBITDA | 6.59B | 3.67B | 7.79B | 6.29B | 7.83B | 7.32B |
| Net Income | 2.81B | 2.69B | 3.28B | 2.40B | 3.83B | 3.46B |
Balance Sheet | ||||||
| Total Assets | 56.83B | 66.95B | 66.10B | 59.72B | 51.28B | 47.05B |
| Cash, Cash Equivalents and Short-Term Investments | 3.52B | 3.68B | 3.60B | 3.65B | 3.25B | 3.68B |
| Total Debt | 21.18B | 27.15B | 28.55B | 22.80B | 18.33B | 18.55B |
| Total Liabilities | 35.73B | 39.49B | 41.26B | 37.90B | 31.63B | 30.99B |
| Stockholders Equity | 21.10B | 27.45B | 24.83B | 21.82B | 19.64B | 16.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.73B | -4.12B | -3.02B | -29.69M | 2.39B |
| Operating Cash Flow | 0.00 | 7.49B | 6.79B | 4.57B | 3.66B | 5.81B |
| Investing Cash Flow | 0.00 | -4.87B | -11.97B | -7.59B | -3.27B | -3.42B |
| Financing Cash Flow | 0.00 | -2.55B | 5.19B | 3.60B | -406.16M | -2.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥123.26B | 29.48 | ― | 0.67% | 8.51% | -17.90% | |
73 Outperform | ¥179.45B | 16.42 | 4.41% | 3.80% | -4.32% | 27.07% | |
64 Neutral | ¥808.89B | 17.47 | 4.79% | 4.21% | -4.09% | -27.31% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥947.43B | 13.44 | 8.79% | 2.68% | -10.66% | 57.43% | |
60 Neutral | ¥485.78B | 16.09 | 1.02% | 3.37% | -1.80% | -85.21% | |
59 Neutral | ¥332.38B | 19.39 | -4.00% | 3.71% | -4.00% | ― |